Exhibit 99.1 uniQure Announces 2025 Financial Results and Provides Recent Company Updates ~ Held Type A meeting with FDA to discuss AMT-130 for Huntington's disease; Company evaluating Phase III development considerations and plans to request follow-up Type B meeting in the second quarter of 2026 ~ ~ Completed enrollment of the first cohort in the Phase I/IIa study of AMT-260 in refractory mesial temporal lobe epilepsy, with additional clinical data expected in the first half of 2026~ ~ Presented updated Ph ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission File Number: 001-40023 GT BIOPHARMA, INC. (Exact name of Registrant as specified in its charter) Delaware 94-1620407 (St ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to _________________ Commission file number: 0-18953 AAON, INC. (Exact name of registrant as specified in its charter) Nevada 87-0448736 (State or other jur ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number : 001-14895 Sarepta Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 93-0797222 (State or other jurisdi ...

Dr. Howard Berger, President and Chief Executive Officer of RadNet, commented, "I am very pleased with the fourth quarter performance. Relative to last year's fourth quarter, Total Company Revenue increased 14.8% and Adjusted EBITDA increased 16.9%, resulting in margin improvement of 29 basis points. This performance was driven by strong aggregate and same center procedural growth, combined with a continued focus on driving operating and clinical efficiencies within the Imaging Center segment. These factors ...

AAON Reports Fourth Quarter and Full Year 2025 Results Carries Record Backlog into 2026 Full Year 2025 Results (All comparisons are year-over-year, unless otherwise noted) Fourth Quarter 2025 Results (All comparisons are year-over-year, unless otherwise noted) Company Introduces 2026 Outlook • 2026 outlook reflects revenue growth of 18-20% and gross margins of approximately 29-31%, supported by record backlog, expanded capacity, and improving operational execution Exhibit 99.1 TULSA, Okla., March 2, 2026 - ...

Financial Performance - Total revenue for 2025 was $5.129 billion, an increase of 5% year-over-year[4] - Adjusted EPS for 2025 was $0.89, up 19% from the previous year[4] - Total revenue for Q4 2025 was $1,276 million, a 1% increase from $1,260 million in Q4 2024[30] - For the full year 2025, total revenue reached $5,129 million, up 5% from $4,898 million in 2024[30] - Operating income for Q4 2025 was $333 million, representing a 9% increase compared to $305 million in Q4 2024[30] - Net income for Q4 2025 was $145 million, a decrease of 23% from $190 million in Q4 2024[30] - The diluted earnings per share for Q4 2025 was $0.17, down from $0.21 in Q4 2024[30] - Net income for the twelve months ended December 31, 2025, increased to $596 million, up 19% from $501 million in 2024[36] - Adjusted income from continuing operations for the twelve months ended December 31, 2025, was $750 million, compared to $685 million in 2024, representing a 9.5% increase[62] Cash Flow and Expenses - Adjusted Free Cash Flow for 2025 was $863 million, an increase of 16% year-over-year[13] - Free Cash Flow for the twelve months ended December 31, 2025, was $716 million, an increase of 17% compared to $612 million in 2024[48] - Adjusted Free Cash Flow for the twelve months ended December 31, 2025, rose to $798 million, up 21% from $659 million in 2024[48] - Selling, general, and administrative expenses decreased by 5% to $360 million in Q4 2025 compared to $380 million in Q4 2024[30] - Interest expense increased by 34% to $110 million in Q4 2025, compared to $82 million in Q4 2024[30] - Interest expense for the twelve months ended December 31, 2025, was $459 million, compared to $441 million in 2024, reflecting a rise of 4.1%[54] Shareholder Returns - The company returned $791 million to shareholders in 2025, including $604 million in share repurchases[14] - The company announced a new $1.5 billion share repurchase authorization effective March 2, 2026[17] Assets and Liabilities - Total assets decreased from $16,051 million in December 2024 to $15,819 million in December 2025, a decline of 1.4%[33] - Long-term debt decreased slightly from $7,511 million in December 2024 to $7,379 million in December 2025, a reduction of 1.8%[33] - Current liabilities decreased from $1,264 million in December 2024 to $1,013 million in December 2025, a decline of 20%[33] - Total stockholders' equity remained relatively stable, decreasing slightly from $3,801 million in December 2024 to $3,779 million in December 2025[33] Operational Highlights - Recurring monthly revenue (RMR) at the end of 2025 was $359 million, with a gross revenue attrition rate of 13.1%[4] - The company launched new safety features and expanded its ADT+ platform, integrating with Google Nest and Yale devices[8] - The company is focusing on integrating AI into its products and services, including customer interactions and operational efficiencies[29] - ADT was added to the S&P SmallCap 600 index effective February 9, 2026, highlighting its strong performance[8] Financial Ratios - The company achieved a net leverage ratio target of 2.5x or below as part of its multi-year financial framework[15] - The net leverage ratio improved to 2.7x as of December 31, 2025, down from 2.9x in the prior year, indicating better credit position[68] Other Financial Metrics - Adjusted EBITDA from continuing operations for Q4 2025 was $670 million, compared to $653 million in Q4 2024, reflecting a year-over-year increase of 2.6%[54] - Adjusted EBITDA margin for Q4 2025 was 53%, slightly up from 52% in Q4 2024, indicating stable operational profitability[54] - The company reported a goodwill impairment charge of $12 million associated with the Multifamily Divestiture during the year[55]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(B) OR 12(G) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended October 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 28, 2026 BIGLARI HOLDINGS INC. (Exact Name of Registrant as Specified in Charter) Indiana 001-38477 82-3784946 (Former Name or Former Address, if Changed Since Last Report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligati ...

Earnings Announcement - Biglari Holdings Inc. announced its earnings for the fourth quarter and year ended December 31, 2025, on February 28, 2026[4]. - The press release detailing the earnings is included as an exhibit to the Form 8-K filing[4]. Annual Report - The 2025 Annual Report to shareholders is available online, including Sardar Biglari's annual letter[6].